3 studies found for: "RWJMS" OR "Robert Wood Johnson Medical School" OR "Cancer Institute of New Jersey" OR "CINJ" | Open Studies | "Tumor Virus Infections"
|1||Not yet recruiting||
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
Avelumab in Subjects With Merkel Cell Carcinoma (JAVELIN Merkel 200)
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
† Study has passed its completion date and status has not been verified in more than two years.